Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats.
Implantation of demineralized bone matrix in rodents elicits a series of cellular events leading to the formation of new bone inside and adjacent to the implant. This process is believed to be initiated by an inductive protein present in bone matrix, and local growth factors may further regulate the process. We have previously shown that local application of recombinant human basic fibroblast growth factor (bFGF) in a carboxymethyl cellulose gel to demineralized bone matrix implants increases the bone yield as measured by calcium content 3 weeks after implantation in rats. We now report that this increase was seen at 3 and 4 weeks, but not earlier or later. Further, the stimulatory effect was seen with doses from 3 to 75 ng per implant. A dose of 0.6 or 380 ng did not increase the bone yield, and 1,900 ng had a marked inhibitory effect. This narrow dosage optimum may reflect the complex actions of the growth factor.
Aspenberg
P
P
Lund University Hospital Department of Orthopedics, Sweden.
Thorngren
K G
KG
Lohmander
L S
LS
D000009:Abdominal Muscles / Q000601:surgery; D000818:Animals; D001857:Bone Matrix / Q000737:chemistry / Q000637:transplantation*; D002118:Calcium / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000494:pharmacology*; D010012:Osteogenesis / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains
D016222:Fibroblast Growth Factor 2; D002118:Calcium